CNTA
Centessa Pharmaceuticals
CNTA
CNTA
44 hedge funds and large institutions have $233M invested in Centessa Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $300M → $233M (-$67.3M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
44
Holding in Top 10
3
Calls
–
Puts
$3K
Top Buyers
| 1 | +$7.4M | |
| 2 | +$6.96M | |
| 3 | +$1.94M | |
| 4 |
Morgan Stanley
New York
|
+$1.11M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$807K |
Top Sellers
| 1 | -$14M | |
| 2 | -$5.23M | |
| 3 | -$1.61M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$567K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$218K |